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Abstract
Significant work has been done modeling cancerous tumor growth and re-
sponse to therapy under certain simplifying assumptions, specifically, the
assumption of spatial homogeneity. We have chosen a spatially heteroge-
nous model for cancer cell growth using a hybrid Lattice-Gas Cellular Au-
tomata method. Cell mitosis, apoptosis, and necrosis are explicitly mod-
eled along with the diffusion of nutrients and a necrotic signal. The model
implementation is verified qualitatively and is modified to execute on a
parallel computer.
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Chapter 1
Introduction
A tumor is an abnormal mass of cells which possess no physiologic func-
tion, that is not inflammatory, and arises without obvious cause from cells
of preexistent tissue. Tumors are categorized as benign or malignant ac-
cording to their effect on the body.
If current trends continue, one out of three Americans will eventually
develop a cancerous tumor. The Center for Disease Control reports that in
1995, an estimated 1,252,000 cases were diagnosedworldwide, with 547,000
deaths in the United States alone (U.S. Department of Health and Human
Services (1995)). With new techniques for detection and treatment of can-
cer, the relative survival rate has now risen to 54 percent. Because the dis-
ease is so widespread it is vital to advance the state of knowledge in this
field as rapidly as possible to understandwhat causes the appearance of tu-
mors, how tumors grow, and how tumors respond to changes in the body
either through the introduction of drugs or through natural bodily mecha-
nisms. In this thesis we consider the second and third research objectives.
1.1 Treatment
Typically, physicians experiment in treating cancer with one of three modes
of therapy: radiation therapy, chemotherapy, and immunotherapy. The
first, and most widely used, involves applying radiation to the tumor cells
which destroys them. Radiation therapy involves the use of highly sophis-
ticated machines to administer treatments. Additionally, radiation therapy
cannot treat all types of tumors. Tumors deep within the body cannot be
treated because surrounding vital tissues may be destroyed. Drug based
therapies like chemotherapy and immunotherapy, are used in those cases.
2 Introduction
1.1.1 Chemotherapy
A more modest mode of treatment, and the most common after radiation
therapy is through the administration of drugs into the body, chemother-
apy. These drugs often are called anticancer drugs.
Normal cells grow and die in a controlled way. When cancer occurs,
cells in the body that are not normal keep dividing and forming more cells
without control. Anticancer drugs destroy cancer cells by stopping them
from growing or multiplying. Healthy cells can also be harmed, espe-
cially those that divide quickly, such as hair, the stomach lining, and the
immune system. Harm to healthy cells is what causes side effects such as
hair loss and nausea. However, these cells usually repair themselves af-
ter chemotherapy (U.S. Department of Health and Human Services (2003)).
Because some drugs work better together than alone, two or more drugs
are often given at the same time. This is called combination chemotherapy.
1.1.2 Immunotherapy
The immune system is able to recognize tumor cells and destroy them.
There are two main types of cells that respond to a tumor’s presence. Non-
specific immune cells, such as NK cells, travel throughout the body’s tissue
and attack all foreign substances they find. Specific immune cells, such as
CD8+ T-cells, attack only after a complex variety of mechanisms primes
them to recognize similar threats (Chang et al. (2003)). The more white
blood cells in the immune system, the more able an individual is able to
fight infection. Although there are other factors affecting the strength of
the immune system, the most common measure of health is the number of
white blood cells, or circulating lymphocytes in the blood stream (Chang
et al. (2003)).
Immunotherapy is similar to chemotherapy in that the patient is in-
jected with a substance. However, the goal of immunotherapy is to boost
the body’s natural cancer fighting abilities. These substances can be made
in the laboratory and given to patients to destroy cancer cells or change
the way the body reacts to a tumor. They may also help the body repair
or make new cells destroyed by chemotherapy. For example, interleukin
2 (IL-2) is a growth factor which causes CD8+ T cell proliferation (Chang
et al. (2003)).
In both immunotherapy and chemotherapy, the tumor and the body can
build resistance to the drugs being administered, diminishing their effect in
time. This is another reason why multiple drugs are used in chemotherapy.
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1.2 Problem Formulation
Planning the administration of drug based therapy into a treatment proto-
col is a complicated process. Physicians working with chemotherapy and
immunotherapy have to decide which drugs to administer, when to ad-
minister them, and in what amounts. Often physicians employ heuristics
in planning. The “Hit it Hard” method, where a large but non-lethal dose
is given at the beginning of treatment with later doses dropping in amount,
is popular among some. However the “slow and steady”, a constant mod-
erate dose, approach is popular among others. However, these are simply
heuristics derived from experimenting with patients in clinical trials.
Clinical trials are expensive, costing about $12,000 to $15,000 for the
treatment of a single patient. Developing new methods of treatment is ex-
pensive. Because of this novel ideas for treatment cannot easily be tested.
There is a high financial cost, but there is also the cost of human lives. Be-
cause of this only the most promising new methods of treatment can be
tested.
1.3 Problem Statement
One of the major stumbling blocks in testing drug therapies is the avail-
ability of a robust model of tumor growth. The problem we consider in
this work is, how can we create an effective numerical simulation of tumor
growth which incorporates the spatial heterogeneity of the tumor, and can
accomodate the addition of chemotherapy and immunotherapy. In build-
ing this framework, we seek to create a model which can be simulated on a
parallel computer, thus reducing the amount of time necessary to compute
our results, or alternatively, increasing the size of the tumors that we can
consider.
We now consider previous approaches to creatingmodels of tumor growth.

Chapter 2
The Model
2.1 Assumptions and Constraints
2.1.1 Assumptions
In order to model cancer cell growth realistically, we must make a number
of assumptions. These include the following:
• Cells in the poopulation are either cancerous or necrotic. There are
many different populations of cells within the body: normal tissue
cells, blood vessel cells, immune system cells, etc. Further, the state
of a cell is so easily differentiated. But because we have concerned
ourselves with modeling the growth of cancerous cells, we consider
their growth in isolation.
• Cells move about a regular 2D square lattice. In reality, cells are not
restricted to a finite set of positions. However, for efficieny in the sim-
ulation of our model we assume that a cell’s motions are restricted.
Additionaly configurations and dimensions could be accomodated,
but for now a 2D lattice must do.
• The size of each cancer cell is uniform across the tumor population
and fixed over time. In reality, cells come in different shapes and
sizes. Further, different cell types have sizes on different scales.
• Necrotic cells occupy less volume than cancerous cells. A cell be-
comes necrotic by dying and bursting its contents into the tumor. The
effect of this is that only one third of the cell is left over.
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• Cells interact locally: the movement and state of a cell can only be
a function of cells adjacent on the lattice. Because there does not
appear to be a background signally network between cells which are
separated by large distances in the body, we assume that the only
interactions that affect the movement and state of a cell are local in-
teractions among adjacent cells on the lattice.
• The local concentration of cells in a specific area affect growth and
movement. We must explicitly model the effect that adjacent cells
have upon each other at the local level.
• Cells are memory less: the probability a cell expires is not depen-
dent on the lifetime of the cell. In reality, as a cell ages its internal
machinery deteriorates and becomes unable to function properly. We
approximate this by simply assuming each cell has an equal baseline
probability of dying pd which is augmented by the presence of nutri-
ent, other cells, and necrotic signal.
• Cell growth is dependent only on the number of cells in a local
neighborhood, the concentration of nutrient, and the presence of
necrotic signal.
• Tumor mass is avascular. Blood vessels are not part of the tumor. We
are simulating a in vitro experiment and vascularization has not been
observed in vitro. Adding a blood vessel network is addressed in 4.
• Nutrient distribution is applied uniformly outside the tumor pop-
ulation. After each step in the tumor simulation we re-fresh the con-
centration of nutrient outside the tumor population while leaving un-
touched the concentration within the tumor. This corresponds to the
in vitro growth protocol of pouring nutrient solution over the tumor.
• There are no other forces affecting cell growth or death. While there
are a number of other factors which effect cell growth and death, we
only concern ourselves with those discussed above.
2.1.2 Constraints
• The model must encompass mitosis, apoptosis, and necrosis. These
basic cellular functions (division, death, and unnatural death) must
be explicitly addressed by the model. Necrosis is when a cell swells
and bursts forming a necrotic site. The presence of a necrotic site
inhibits neighboring cells from entering mitosis (?).
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• Cells must respond to the presence of other cells. Cells divide,
move, and die because of the presence of other cells. If there are too
many cells at a lattice site, then there is no room for a new cell to be
placed. If there is room for a new cell, we would expect because of
themechanical pressure of neighboring cells that the new cell tomove
towards the direction of least cellular concentration. These physical
realities must be addressed in our model.
• Cells must be both added and removed from the system. It is a fact
that biological systems both grow and die. Our model must incorpo-
rate both cell division, and death. It must also deal with the disposal
of dead cells from the system through some sort of purging process.
• The model must address specifically address spatial heterogeneity.
Themain drawbackwith the ODEmodels is that they do not consider
the spatial distribution of tumor cells or nutrients. This is the advan-
tage of PDE models. We hope to sidestep some of the drawbacks of
the PDE models while still embracing spatial heterogeneity.
• The model must be extendable to include chemotherapy and im-
munotherapy. The whole purpose of creating this model is so that
we have a suitable framework to explore new treatment protocols. If
we cannot guarantee that chemotherapy and immunotherapy can be
accomodated, then we are heading down the wrong path.
2.2 Hybrid Lattice-Gas Cellular Automata Model
The model we choose to work with is a hybrid Lattice-Gas Cellular Au-
tomata model first considered in Dormann and Deutsch (2002). In the
rest of this work, we summarize their model, and make improvements in
the implementation to accomodate larger tumors than those considered by
Dormann and Deutsch (2002).
2.2.1 Lattice-Gas Methodology
Lattice-Gas models are concerned with modeling microscopic phenomena
in a way which provides a macroscopic reality. In Lattice-Gas models, par-
ticles are modeled explicitly as moving along a fixed lattice with some ve-
locity and fixed methods of interaction amongst particles.A very thorough
treatment of the history and application of Lattice-Gas models to a diverse
set of physical problems is Chopard et al. (1998).
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Our model adds a little bit to the regular Lattice-Gas automaton. Our
model consists of a regular lattice which is populated by some number of
particles. Each particle contains both a state and a velocity. Each particle
corresponds to a biological cell. The state of each particle indicates whether
or not the cell is cancerous or necrotic, and if it is cancerous whether it is
dividing (mitosis) or not (apoptosis).
At each time step the model is updated in two ways. First, the velocity
of each cell determines where on the lattice, if space is available, the cell
moves next. Second, the state of the cell is updated according to the state
transition diagram shown in 2.1.
Each lattice site ~x in our model contains four transport channels cˆi and
one rest channel, cˆ0. Cells in the rest channel have no velocity. While cells in
the four transport channels have unit velocity in the direction correspond-
ing to their transport channel. Each channel can accomodate at most one
cell. The configuration of each lattice site is depicted in 2.2.1.
At each time step the particles in the model move in the direction of
their velocity vector. When a particle encounters a boundary, it has its ve-
locity reversed. This is depicted in 2.3.
When particles collide with each other, they are redirected along an or-
thogonal axis. This is depicted in 2.4.
As cells need food to live, our model incorporates a background nutri-
ent gradient which is evolved according to the diffusion equation on a lat-
tice of the same size and dimension as the lattice of tumor cells. Addition-
ally, it has been noted (?, ?) that there is a necrotic signal gradient created
by the presence of necrotic cells. Our model incorporates this additional
background necrotic signal in the same manner as the nutrient gradient.
Let the probability that a quiescent cell enters mitosis be pm. Then in
light of our modeling assumptions and constraints, the probability that at
time t a cell at lattice site ~x divides p¯m(~x, t) is a function of pm, the number
of and type of neighboring cells, and the presence of nutrient and necrotic
signal.
Let the number of cancerous cells at a lattice site be defined as nC(~x, t),
and the number of necrotic cells at a lattice site nN(~x, t). The total number
of cells at a lattice site is n(~x, t) = nN(~x, t) + nC(~x, t). The amount of nu-
trient at a lattice site is cnut(~x, t), while the minimum amount of nutrient
necessary to sustain cellular life is tnut.
Then the probability that a quiescent cell enters mitosis depends first
upon the presence of necrotic cells and the concentration of nutrient. If
necrotic cells are present, thenmitosis in inhibited. Otherwise, if the amount
of nutrient is sufficient to support the current amount of cells at the min-
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imum level, then we divide as the function defined below from Dormann
and Deutsch (2002),
p¯m(r) =
{ pm
nC(~x,t)
(
Cnut(~x,t)−tnut
1−tnut
)
, if nN(~x, t) = 0 and Cnut(~x, t) > nC(~x, t)tnut,
0, otherwise.
Similarly, a cell enter apoptosis with probability pd augmented if there
is not enough nutrient available. The probability of death is hastened by the
presence of other cells, all competing for available nutrient, which gives the
function,
p¯d(~x, t) =
{
pdnC(~x, t), if Cnut(~x, t) > nC(~x, t)tnut,
0, otherwise.
A cell becomes necrotic if there is no longer enough nutrient to sustain
the cells at the lattice site. There is a chance that a cell becomes necrotic if
there are other cells at the lattice site, but there is still enough nutrient avail-
able. This probability is pn, and we compute the probability for transition
as,
p¯n(~x, t) =

0, if nN(~x, t) = 0 and Cnut(~x, t) > nC(~x, t)tnut,
pn, if nN(~x, t) > 0 and Cnut(~x, t) > nC(~x, t)tnut,
1, otherwise.
In this way our model explicitly addresses the issue of spatial hetero-
geneity. We are considering the local presence of cells and their intercom-
petition for resources. Additionally, at each time step, a fraction of dead
cells and necrotic cells are removed from the lattice, thus making room for
new cells.
This model diverges from traditional cellular automata models in that
cells move about a lattice and can populate other cells in the lattice. In a
cellular automata model, cells remain fixed on their lattice. Additionally,
this model diverges from traditional Lattice-Gas automata models in that
each particle contains a state variable which indicates whether or not the
cell is necrotic.
To summarize, the main features of our model are:
• State.
This is the idea we are borrowing from traditional cellular automata.
The state is simply a value from a finite set. In our model they will
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indicate whether a cell is cancerous and dividing, cancerous and qui-
escing, or necrotic.
• Transport channels.
The channels, depicted in 2.2.1 are central to moving the cells along
the lattice. This is where the model diverges from traditional cellular
automata. Cells have velocity and enter and exit between channels
on the lattice. This allows cells to populate other areas of the lattice
without necessarily growing a stream of cells.
2.3 Advantages and Disadvantages
Here we consider the relative merits of our hybrid LGCA model.
2.3.1 Advtanages
• Flexible. The lattice size can be increased to accomodate larger tu-
mors.
• Simple to understand.
There is a direct correspondance between cells in the model and bi-
ological cells in the computer simulation. Qualitative understanding
of the models behavior can be immediately interpreted.
• Easy to simulate.
The execution of the model consists of a series of simple identical
steps. While the computations may be many, their individual com-
plexities are small.
2.3.2 Disadvantages
• Not easy to perform traditional analysis. Unlike the work done with
ODE and PDE models, there is no phase space. We cannot analyti-
cally determine the long term behavior of the system given the initial
conditions. We can only take a statistical average of the simulations.
This is somewhat unsatisfactory.
• Parallelization requires a little bit of effort. Nothing in life is free.
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2.3.3 Preference Weighting
When a cell divides we do not simply place its offspring in a random trans-
port channel. Instead, we consider a preference weighting. In light of our
assumptions and constraints, a cell should prefer to be in an area of high
nutrient concentration, and low competition with other cells. That is, given
the choice between two lattice sites, the new cell would on average choose
the less crowded, more nutrient rich one.
It is still possible for a cell to move towards an area of high concentra-
tion, especially if there is the presence of necrotic signal.
What we seek is a probability distribution function to be computed for
a lattice site each time a cell divides. The probabilities of each transport
channel are computed, and a random sample is taken. In our model we
consider a linear function which combines the amount of necrotic signal,
and the number of cells in the neighboring lattice site.
pre f (~x, t) = 5csig(~x− cˆi)−
4
∑
i=0
ni(~x− cˆi, t) (2.1)
When the concentration of necrotic signal is maximal, the only thing
that can dissuade a cell frommoving towards that lattice site is the total oc-
cupation of that site. If the necrotic signal is constant among all the neigh-
boring lattice sites then the sites are ordered according to their population.
2.3.4 Cellular Collision
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Figure 2.1: State Transition Diagram for Cancerous Cells
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Figure 2.2: A 2D square lattice site with rest channel (center) and four trans-
port channels: north, east, south, west.
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Moving East Moving North
Colliding with Boundary to the East Colliding with Boundary to the South
Figure 2.3: Dynamics of particles with respect to velocity
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Figure 2.4: Dynamics of particles with respect to collisions
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2.4 Diffusion of Signals
The model simulations investigated in Dormann and Deutsch (2002) were
limited by the computational power available to a 200 × 200 lattice. On
such a small lattice one cannot hope to simulate tumors which physicians
could detect and identify as candidates for treatment with chemotherapy or
immunotherapy. The principal computational limitation in Dormann and
Deutsch (2002) was their use of the unconditionally stable Crank-Nicholson
scheme in simulating the diffusion over time of the concentration nutrient
and the necrotic signal ρ(~x, t) using the diffusion equation with coefficient
of diffusion D:
∂ρ(~x, t)
∂t
= D∇2ρ(~x, t). (2.2)
Such a scheme involves the inversion of a tridiagonal matrix equation
at each time step and cannot easily be parallelized.
In this chapter we consider an alternative approach to the diffusion
problem: using a similar lattice-gas automata, LGA, method as our model
of tumor growth. The benefits are a simple, parallelizable implementation,
and the potential re-use of code from our tumor model implementation.
2.4.1 Background of the Lattice-Gas Method
As discussed in ?, LGA-like models have long been studied in pysics as
theoretical models of molecular dynamics. The first LGA models were in-
troduced for the theoretical study of fluid flow (?). It was later realized that
the locality, uniformity and spatial regularlity of models based on LGA’s
make them ideal candidates for large-scale simulation on parallel hard-
ware (?,?,?). Since then, LGA simulations have been used to study a variety
of physical pehnomena, including fluid dynamics, chemical reactions, and
phase changes (?, ?, ?, ?, ?), and diffusion (?).
The principal ideological advantage of LGA models is that the com-
puter model is the same as the theoretical model. This is unlike models
based on partial differential equations, for example, where an intervening
stage of numerical analysis is needed. LGA models and related modeling
techniques have both a theoretical and practical aspect, providing simple
models that we can directly experiment with, visualize, and analyze math-
ematically.
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2.4.2 Lattice-Gas Method Applied to Diffusion
The method we develop for modeling diffusion considers particles at the
microscopic scale and recovers 2.2 in the limit of an infinitely fine lattice.
The method we present was first introduced by ?, the presentation and
analysis is from Chopard et al. (1998) and D’Souza et al. (2001).
Consider a two-dimensional square lattice with particles hopping be-
tween adjacent sites of the lattice with unit velocity. Each lattice site has
four transport channels Ni(~x, t), along each lattice direction cˆi, at each site ~x
at time t, where i ∈ {0, 1, 2, 3}, can either be occupied (with a particle to be
moved) or empty. That is, Ni(~x, t) = 1 or 0 respectively. Since there are four
channels at each lattice site, there can be up to four particles at each site. At
every integer time, the particles can move in one of four directions corre-
sponding to the four lattice directions: north, south, west, or east. Note that
there is no rest channel here. Particles always have some velocity.
The dynamics of the model are decomposed into two phases: interation
and streaming. Each unit time step in the simulation is composed of these
two phases. We denote the state of the system at the fractional time step
after interaction but before streaming as N′i (~x, t).
In the interaction phase, the velocity of particles are altered according
to our local interaction rules. In the streaming phase, particles move along
the lattice in the direction of their transport channels. If we were to remove
the interaction phase, all particles would continue in their initial direction
indefinitely.
The interaction rule considered in Chopard et al. (1998) had each chan-
nel at each site ~x at time t randomly permuted with each other channel
at the site. This was done by a probabilistic function r(~x, t) ∈ {0, 1, 2, 3}
which rotated each channel by r(~x, t) · pi/2 radians. The introduction of
r(~x, t) allows the particles to execute simultaneous random walks on the
lattice.
Thus after the permutation,
N′i (~x, t) = Ni+r(~x,t)(~x, t) (2.3)
After the streaming phase, each transport channel is occupied by the
particle from the adjacent lattice site in the transport channel in the direc-
tion opposite. That is, a north bound particle moves into the south trans-
port channel of its northern neighbor, and vice versa. This can be summa-
rized by the equation,
Ni(~x, t+ 1) = N′i (~x− cˆi, t) = Ni+r(~x−cˆi ,t)(~x− cˆi, t) (2.4)
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Note that (cˆi = −cˆi+2).
The principle advantage to using a LGA model in describing diffusion
is that our computer implementation of themodel is quite straight forward.
At each time step we take each lattice point and randomly permute the par-
ticles present in its velocity channels. We then stream each particle in the
direction of its velocity into adjacent lattice sites onto a new empty lattice.
Once all the particles have been streamed, we copy the new empty lattice
onto our old lattice and repeat the procedure.
By appropriately choosing the probability distribution for r(~x, t), one
can control the average number of steps in a particular direction a par-
ticle advances before it has its velocity altered. This, and the number of
iterations we run our simulation for, allows us to control the coefficient of
diffusion D.
Though Chopard et al. (1998) consider amore general model for particle
interaction, we will show that when r(~x, t) is uniformly distributed among
the four transport channels the resulting model converges to the diffusion
equation 2.2 in the limit of an infinitely fine lattice. We show this result
through the lattice-Boltzmann statistical averaging method.
If we take the expected value of 2.4,
E[Ni(~x, t+ 1)] = E[Ni+r(~x−cˆi ,t)(~x− cˆi, t)] (2.5)
= E[
1
4
3
∑
j=0
Nj(~x− cˆi, t)] (2.6)
=
1
4
3
∑
j=0
E[Nj(~x− cˆi, t)]. (2.7)
We define the occupation number of each channel as ni(~x, t) = E[Ni(~x, t)],
then the lattice-Boltzmann equation for our system is,
ni(~x, t) =
1
4
3
∑
j=0
nj(~x− cˆi, t). (2.8)
We define the total density of a lattice site ρ(~x, t):
ρ(~x, t) =
3
∑
i=0
ni(~x, t). (2.9)
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Combining 2.9 and 2.8,
ρ(~x, t+ 1) =
3
∑
i=0
ni(~x, t+ 1) (2.10)
=
1
4
3
∑
i=0
[
3
∑
j=0
nj(~x− cˆi, t)
]
(2.11)
=
1
4
3
∑
i=0
ρ(~x− cˆi, t). (2.12)
We now take the limit as the time step ∆t and the lattice spacing ∆x both
approach zero while (∆x)2/∆t approaches a constant.
We take the Taylor expansion of ~x in 2.10 to order (∆x)2,
ρ(~x, t+ 1) =
1
4
3
∑
i=0
[
3
∑
j=0
nj(~x, t) + ∆x(cˆi · ∇)nj(~x, t) + (δx)
2
2
(cˆi · ∇)2nj(~x, t)
]
(2.13)
= ρ(~x, t) +
(∆x)
4
3
∑
i=0
3
∑
j=0
(cˆi · ∇)nj(~x, t) (2.14)
+
(∆x)2
8
3
∑
i=0
3
∑
j=0
(cˆi · ∇)2nj(~x, t) (2.15)
Simplifying 2.13 we obtain,
ρ(~x, t+ 1) = ρ(~x, t) +
(∆x)2
4
∇2ρ(~x, t).
Which when Taylor expanded to order (∆t) we obtain the diffusion
equation,
∂ρ(~x, t)
∂t
= D∇2ρ(~x, t).
where the diffusion constant, D = (∆x)2/(4∆t).
2.4.3 Results of Diffusion Simulation Using a Lattice-Gas Code
The simulation results for our method confirm qualitatively our belief that
at the microscopic level the Lattice-Gas approximates the diffusion process.
In the first simulation, a 100× 100 square is diffused for 3000 iterations.
As the number of iterations increases the particles composing the rectangle
execute simultaneous random walks with exclusion on the lattice. After 1
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iteration, not every site on the lattice originally part of the rectangle is occu-
pied. After 1000 iterations, the shape of the square is present, but ambigu-
ous. After 3000 iterations, the shape of the square has all but disappeared.
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Figure 2.5: Lattice-Gas Diffusion on 100x100 Rectangle
In our second simulation, a triangle with base and height of length 100
is diffused for 3000 iterations. Again, as the number of iterations increases,
the initial shape of the particles is made more ambiguous. After 3000 itera-
tions, the shape of the distribution is indistinguishable, aside from the total
quantity of cells, from the final shape in 2.5.
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2.4.4 Conclusion on Diffusion
While the analysis and simulations are promising, we note that the LGA
method does not exactly model diffusion, but that on the whole all the
simulations will statistically average to diffusion.
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Figure 2.6: Lattice-Gas Diffusion on 100x100 Triangle
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2.5 Parameter Estimation
Because this model is a re-implementation of the work in (Dormann and
Deutsch (2002)), we calculate parameters as in their work.
• Volume of tumor cells. In our model we will consider V-79 cells. V-
79 cells are commonly used as targets in toxicity studies, and other in
vitro experiments.
From the literature (?), our cells have a volume of Vc = 3.351 ×
10−5mm3.
• Volume of necrotic cells. We assume that necrotic cells occupy one
third of the volume of a regular tumor cell, Vn = 1.117× 10−5mm3.
• Length of lattice. We follow the modeling assumption in (Dormann
and Deutsch (2002)) that cells are packed in the volume of a cubic
lattice node which is chosen to be twice the volume of one tumor cell,
6.7× 10−5mm3 (?). Thus the length of a square lattice area is,
∆l = (2×Vc)1/3 = (6.7× 10−5mm3)1/3 = 0.04mm. (2.16)
• Scale of cellular dynamics.
Tumor cells have slower dynamics than the chemical signals. Cell
dynamics are observed on the order of an hour, while chemical dy-
namics are observed on ther order of a minute (?). Time step for
cell dynamics, ∆k = 1hour. Time step for chemical diffusion, ∆kd =
1minute.
• Diffusion coefficient of nutrient and necrotic signal.
We make the simplifying assumption that the coefficient of diffusion
for the nutrient and the necrotic signal are the same.
D = 10−6
cm2
s
= 3.64
∆l2
min
(2.17)
• Glucose uptake rate. Studies from the literature (?) show that if the
external glucose concentration is approximately,
1.15× 10−5 mg
mm3
= 7.7× 10−8mg
∆l3
,
24 The Model
then the consumption rate of glucose is,
7.2× 10−8 mg
cell− hour
So during a one hour period, a cell at a lattice site will consume all
available nutrient.
c¯nut = 1
1
cell− hour (2.18)
• Critical glucose concentration The amount of glucose necessary to
sustain a cell is,
1.4× 10−4 mg
mm
3
= 9.38× 10−9mg
∆l3
.
The critical glucose concentration, the percentage of normal consump-
tion that can sustain a cell’s life, is then,
tnut =
9.38× 10−9 mg∆l3
7.7× 10−8 mg∆l3
= 0.12 (2.19)
• Doubling Times V-79 cells divide between 10 and 19 hours (?, ?). If
we fix the doubling time at 16 hours, if we assume that the population
initially grows exponetially, then the initial growth rate, the difference
between the rate of mitosis and apoptosis (death), is,
pm − pd = log 216hour = 0.04/hour (2.20)
• Rate ofMitosisWe take the rate ofmitosis fromDormann andDeutsch
(2002) with no further justification.
pm = 0.05/hour (2.21)
By 2.20, we compute the rate of apoptosis as,
pd = pm − 0.04/hour = 0.01/hour (2.22)
• Other parametersWe set the remaining parameters to the values pub-
lished in Dormann and Deutsch (2002).
Necrosis rate,
pn = 8× 10−3. (2.23)
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The rate for dissolution of necrotic cells from the system,
qd = 5× 10−4. (2.24)
Production rate for necrotic signal by necrotic cells,
c¯sig = 1. (2.25)
The decay rate for necrotic signal from the system,
ssig = 0.4. (2.26)
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2.6 Implementing the Model
In this section we discuss the implementation of the model’s simulation:
the proliferation of cells and the diffusion of nutrient and necrotic signal.
2.6.1 Procedural Outline
Our simulation follows these steps at each iteration:
1. Initialize the lattices for the tumor, nutrient, and necrotic signal.
2. First decay the necrotic signal, then remove any signal outside the
tumor.
3. Refill nutrient on the lattice outside the tumor.
Start parallel processing by applying the following rules to each site on the lattice.
4. If the number of necrotic cell is greater than 0, remove each necrotic
cell with rate qd.
5. If the rest cell is in the proliferating state, and not all transport chan-
nels are occupied, create a new cell and place according to the prefer-
ence weight.
6. Consume available nutrient if proliferating, or quiescent.
7. Remove all cells entering apoptosis.
8. For all cells entering necrosis, update state, add signal to necrotic sig-
nal gradient.
Stop parallel processing
9. Diffuse the necrotic signal and nutrient on their respective lattices.
10. Move cells according to their velocity vectors. Handle collisionswhere
appropriate.
2.6.2 Implementing the Model
In this section we discuss the particulars of implementing our model.
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• Lattice Representation. Because we are constrained to a 2D lattice,
we represent by a 512× 512 array of lattice points. Each lattice point
is a structure containing five pointers to cells representing each trans-
port channel: north, south, west, east, and rest.
The nutrient and necrotic signal lattices are similar, but they do not
compute with the rest channel.
• cell
Each cell is a state and velocity pair. Each state is an integer represent-
ing the various states a cell may occupy: 0 - dividing, 1 - quiescing,
2-necrotic, 3-dead.
• Rates ofDiffusion The nutrient diffuses at the same rate as the necrotic
signal, however the cells moves at a much slower rate.
We reconcile this by running the diffusion simulation for more time
steps for the nutrient and necrotic signal than the cells. We run the
nutrient diffusion for 1000 time steps, andwe run the cellular diffusion
for 300 time steps.
• Handling Collisions.
Collisions between cells are handled by the routine whichmoves cells
along the lattice in the direction of the transport channel. If two cells
collide, they swap proceed to their neighboring lattice site, but ex-
change positions with an orthogonal particle, if present. That is, if a
particle is heading north and is collided by a particle heading south,
then the two particles are placed in the east and west transport chan-
nels instead of the rest channel.
• probabilistic functions One speed bottle neck is the implementation
of the stochastic function r(~x, t) which helps us to permute the parti-
cles in the nutrient and necrotic signal diffusion processes. We use the
Unix rand(1) command to supply ourselves with a series of random
numbers. rand(1) is useful because if we supply it with a fixed seed,
we will always obtain the same series of random integers. This is use-
ful if we would like to re-simulate an interesting run of our model.
Alternatively, we could use pre-computed randomnumbers from rand(1)
or a website. However, we do not currently handle this.
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2.7 Parallelizing the Code
One of the hallmarks of lattice-gas methods is that they are easily am-
menable to implementation on a parallel computing platform.
2.7.1 Choosing a computing platform
The question we ask ourselves is which computing platform should we use
for our simulation.
1. Vladymir There exist in the public domain several codes to execute
Lattice-Gas methods on parallel hardware. None is as promising as
the recently released Vladymir library from Jonas La¨tt (?). Vladymir
can be parallelised in a completely implicit way: any program that
runs on one processor will also run on a parallel machine, without
any changes. However, you need to have PVM (discussed below)
installed in order to use the parallel features.
Also, since this library is only preliminary release, and most of the
documentation is in French, the library remains on the border of suit-
ability for our needs.
2. MATLAB MATLAB from The Mathworks is a general computing
platformwhich offers some parallization features. However, theMAT-
LAB compiler is an expensive addition, and in the author’s experi-
ence, difficult to use.
3. General computing platforms
The Parallel Virutal Machine system (PVM) is a portable message-
passing programming system, designed to link separate hostmachines
to form a virtual machinewhich is a single, manageable computing re-
source. The virtual machine can be composed of hosts of varying
types, in physically remote locations. On the one hand, PVM is avail-
able free of charge, easy to target, and debug. On the other hand,
PVM is difficult to maintain and requires the attention of a system
administrator.
MPI, the Message Passing Interface, is a bare-bones alternative to
PVM. The programmer is responsible for configuring the system and
ensuring that it is in working order before and during the computa-
tion. The trade-off is that MPI gives the programmer greater control
over all aspects of parallelization.
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Ultimately, we chose to use the PVM library to parallelize the code. This
choice, in light of an able system administrator, allowed us to quickly lever-
age our exisiting serial code into a parallel code. We simply instruct the
PVM to process each lattice interaction independently. We then reconstruct
the solution on a single processor. The overhead involved in reconstucting
the solution is minimal, but could be avoided if more thought was given to
the matter.
The simulation scaled well to the four processors that were ultimately
tested. From taking 3 minutes on a Pentium-4 to run a simulation of the
model corresponding to 100 hours of cellular growth, the run took only 1
minute.
More parallelization is possible by cutting PVM out of the equation.
However, doing so would introduce more overhead in the simulation code.
The overhead involved in a parallel computation is governed by Ahmdal’s
Law, described below.
2.7.2 Overhead and Ahmdal’s Law
The speed of a program is the time it takes the program to excecute. Speedup
is defined as the time it takes a program to execute in serial (with one pro-
cessor) divided by the time it takes to execute in parallel (with many pro-
cessors). The formula for speedup is:
S =
T(1)
T(j)
Where T(j) is the time it takes to execute the program when using j
processors. Efficiency is the speedup, divided by the number of processors
used. Due to the cost of multiprocessor super computers, one must make
sure that the marginal utility of the time and money spent building the
computer is large enough, and not negative.
Amdahl’s Law is a law governing the speedup of using parallel proces-
sors on a problem, versus using only one serial processor.
A Speedup Curve is simply a graph with an X-axis of the number of
processors, compared against a Y-axis of the speedup. The best speed we
could hope for, S = N, would yield a straight 45 degree curve. That is, if
there were ten processors, we would realize a ten fold speedup. Anything
better wouldmean that the program ran faster on a single processor than in
parallel, which would not make it a good candidate for parallel computing.
When B is constant Amdahl’s Law predicts a speedup curve which is log-
arithmic and remains below the line S=N. This law shows that it is indeed
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the algorithm and not the number of processors which limits the speedup.
Also note that as the curve begins to flatten out, efficiency is drastically
being reduced.
2.7.3 Implementation Conclusion
We first implemented the model on a serial computer using the C program-
ming language. We then adapted the code to use the PVM system to exe-
cute the code on multiple computers in a cluster. We used only 4 comput-
ers, where each lattice (cellular, nutrient, necrotic) was quartered and sim-
ulated on each processor. The number of computers used in parallel could
be increased by a factor of 2 or 4 with a little more work. The overhead in-
volved in adding new processors is making sure that the interaction phase
of the lattice-gas method correctly communicates the position of particles
moving between the pieces of lattice each processor is assigned.
Alternatively, each lattice could be evolved separately on three com-
puters. This would involve only minimal overhead in communicating the
results of each evolution between the three computers. However, extend-
ing this approach beyond the number of lattices present produces the same
concerns of complexity and overhead as in the approach considered above.
Chapter 3
Results
In this section we discuss the results of simulating the model under a num-
ber of initial conditions and analyze the performance of the model. While
the simulation was generally stable, the performance of the model was not
the holy grail of cancer simulation I had been looking for.
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3.1 Experiments
In each of our experiments we consider the following protocol
We run the following three experiments to validate that thismodel qual-
itatively reflects clinically observed principals of biological growth.
Turning off the necrotic signal
Withholding nutrient after the tumor has grown a bit.
Seeing how the tumor responds to changing the diffusion parameter.
Results: 1) the tumor grows without bounds while this is not observed
in other in vitro studies this is to be expected. there is nothing inhibiting
growth except for a lack of nutrients, but nutrients are constantly being
refreshed.
2) the tumor dies because it has no food. it would be disturbing if the
tumor did otherwise.
3) for large value of nutrient diffusion, it should be like adding nutrient
to the entire lattice, not just outside the tumor
for small values of nutrient diffusion, the core should die because the
nutrient is not making it to the center of the tumor
for intermediate values, the growth should be similar to normal tumor
growth
where are the thresholds between these regimes?
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3.2 Performance
How well does the code scale up?
From 1 to 4 processors.
Again, Amdahl’s law starts to come into play
If the dimension of the mesh is a lot larger than the number of proces-
sors then we can get away with lots of parallelization.
The valdymir library goes a long way to speed up this process, unfor-
tunately it’s in French and still in early releases.

Chapter 4
Possible Extensions to the
Model
4.1 Other Geometries
Currently our hybrid LGCA simulation takes place on a 2D square lattice.
Other Lattice-Gas models have been implemented on 2D hexagonal lat-
tices, depicted in 4.1, and 3D square lattices. Because the diffusion pro-
cess is implemented as a Lattice-Gas model, its underlying lattice can be
extended with the tumor simulation. And because we are using the di-
mension splitting technique described in D’Souza et al. (2001), adding ad-
ditional dimensions to our model of diffusion is simple and does not alter
its convergence to the continuous diffusion equation in the limit of an in-
finitely fine lattice.
4.2 Additional Cellular Populations
In our current simulationwe have limited ourselves to only cancerous cells.
This restriction can be relaxed and we can add new states for the cells to
accomodate a normal cell population, a competing population of cancer
cells, or even immune cells.
Normal cells would consume nutrient, birth, live, and die at rates dif-
ferent from cancerous cells, but would occupy the same amount of space as
cancerous cells.
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4.3 Immune Cell Populations
Because immune cells interact with normal and cancerous cells they would
need special consideration in the simulation. Their effectiveness would be
diminished after each interaction with normal and cancerous cells. Addi-
tionally, the preference weighting function for immune cells would have
to favor the cell moving towards areas of high cellular concentration in-
stead to areas of low concentration. The transition probabilities for normal
and cancrous cels would need to be changed to incorporate the presence of
immune cells.
4.4 Blood Vessel Networks
Alarcon, Byrne, and Maini Alarco´n et al. (2003) consider the effect a net-
work of blood vessels which diffuse nutrient have on the growth of tumors.
Their work considers the presence of a connected set of blood vessel cells
on a 2D square lattice. Their model shows a dependence of the growth of
tumors on the shape of the hemotopy, blood flow. A similar addition could
be made to our hybrid LGCA model in either one of two ways.
First, add static background blood vessel lattice could be constructed
that would diffuse nutrients. Nutrient would be replenished at some rate
on the cellular lattice only where blood vessels were present in the back-
ground blood vessel lattice. This is in contrast to our current simulation’s
in vitro style application of nutrient everywhere on the lattice that is not
currently occupied by a cell.
Alternatively, a static blood vessel cell could occupy the cellular lattice
in addition to the other cells in the simulation. These cells would remain
fixed on the lattice and thus not be subject to the streaming phase of the
model. This would more closely model the physical reality of blood vessels
having some volume.
In Alarcon, Byrne, andMaini’s model of the blood vessel networkAlarco´n
et al. (2003), the blood vessels are allowd to reorganize and change the dis-
tribution of nutrient between iterations of the model. If we require that the
set of blood vessel cells remain connected, it is not entirely clear that our
hybrid LGCA model could observe this constraint and still remain paral-
lizable.
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4.5 Chemotherapy Protocols
Perhaps most importantly, chemotherapy can be introduced easily. If we
consider chemotherapy as another background signal like nutrient and necrotic
signal, we simply add another diffusion computation to our model. We
would have to modify the transition probabilities for all cells involved, as
chemotherapy kills normal cells as well as cancerous cells.
Implementing chemotherapy in this way for our hybrid LGCA model
makes for a straight forward testing of protocols for chemotherapy. After
a number of iterations, we augment the background chemotherapy signal,
and continue running iterations of the model while the chemotherapy sig-
nal is periodically diffused.
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Figure 4.1: Hexagonal Lattice with Rest Channel and Six Velocity Channels
Chapter 5
Closing Remarks
We have found the following.
Parallel computing is an effective method for speeding up the simu-
lation of our hybrid LGCA model. Because each iteration of our hybrid
LGCAmodel executes many independent computations, each iteration can
be broken up amongst many different processors in a parallel computing
system.
PVMmakes a good platform to test these methods. Though once a code
has matured, it should be adapted to an explicitly parallel library, such as
MPI, as that would give the most control over the details of parallelization
and minimize the amount system overhead.
Parameters are sensitive to change. Accurate parameter estimation is
necessary in order to have an accurate and predictive model.
There are many types of cancers. Biological research has shown that
these different cancers depend upon a number of different factors. An im-
portant factor to breast cancer may be relatively unimportant in prostate
cancer. Currently, the practice in mathemtical modeling is to accumulate
values for parameters from disparate studies in the biological literature.
While the rate of diffusion of nutrient may be taken from a mouse study,
the rate of cellular division may be taken from a primate study. It is not
clear whether this practice is appropriate.
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